111 related articles for article (PubMed ID: 25336562)
1. Colorectal cancer screening in first nations people living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Musto G; Shu E; Biswanger N; Elias B; Griffith J; Turner D
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):241-8. PubMed ID: 25336562
[TBL] [Abstract][Full Text] [Related]
2. Reducing income-related inequities in colorectal cancer screening: lessons learned from a retrospective analysis of organised programme and non-programme screening delivery in Winnipeg, Manitoba.
Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
BMJ Open; 2016 Feb; 6(2):e009470. PubMed ID: 26908517
[TBL] [Abstract][Full Text] [Related]
3. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Rates of Colon Cancer Screening Use in Winnipeg, Canada: The Experience of a Universal Health-Care System with an Organized Colon Screening Program.
Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
Am J Gastroenterol; 2015 Dec; 110(12):1640-6. PubMed ID: 26169513
[TBL] [Abstract][Full Text] [Related]
5. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
7. Mammography rates for breast cancer screening: a comparison of First Nations women and all other women living in Manitoba, Canada, 1999-2008.
Demers AA; Decker KM; Kliewer EV; Musto G; Shu E; Biswanger N; Fradette K; Elias B; Griffith J; Turner D
Prev Chronic Dis; 2015 May; 12():E82. PubMed ID: 26020546
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
9. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
10. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
12. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing colorectal cancer screening in rural southern Taiwan.
Lin YH; Kao CC
Cancer Nurs; 2013; 36(4):284-91. PubMed ID: 22964866
[TBL] [Abstract][Full Text] [Related]
14. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer screening.
Bretthauer M
J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
[TBL] [Abstract][Full Text] [Related]
16. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
17. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
[TBL] [Abstract][Full Text] [Related]
18. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
19. Evidence for colorectal cancer screening.
Bretthauer M
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
[TBL] [Abstract][Full Text] [Related]
20. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
